Scientists at the Stowers Institute for Medical Research have reported a detailed description of how function-impairing mutations in polr1c and polr1d genes cause Treacher Collins syndrome (TCS), a rare congenital craniofacial development disorder that affects an estimated 1 in 50,000 live births.
The combination of two plant compounds that have medicinal properties - curcumin and silymarin - holds promise in treating colon cancer, according Saint Louis University research published in the June 23 issue of the Journal of Cancer.
Researchers found that treating metastatic thyroid cancer patients harboring a BRAF mutation with the targeted therapy vemurafenib -- originally approved for melanoma patients with the mutation -- showed promising anti-tumor activity in a third of patients.
(Society of NeuroInterventional Surgery) The Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting -- to be held July 25 - 28 in Boston -- will feature new research and best practices in improving stroke systems of care, addressing difficult stroke cases, understanding interventionalist approaches to oncology, and treating arteriovenous malformations and aneurysms, and more.
(Rochester Institute of Technology) A nearly $4 million grant from the National Institutes of Health will help advance research, teaching experiences and career preparation in the biomedical and behavioral sciences fields for deaf and hard-of-hearing postdoctoral students.